3-bromo-1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-1H-pyrazole-5-carboxamide(CAS: 736994-63-1)

This compound is subject to regulations under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH in Europe, and FDA/EPA guidelines in the USA. GHS classifications may include flammability, reactivity, and toxicity categories, while REACH requires detailed safety data sheets and a substance registration. FDA regulations focus on the use of the compound in pharmaceuticals, while EPA guidelines address environmental and health impacts during production and usage.

Alternative reagents for synthesis include bromine and various pyridine derivatives. Isomers like 2-bromo-1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-1H-pyrazole-5-carboxamide or analogs with different substituents on the pyrazole ring can be used. These alternatives can offer similar or enhanced properties, depending on the specific application.

The market for this compound is growing due to its potential applications in antiviral and anticancer drugs. Research trends focus on its biological activity and SAR studies. Price trends show an upward trend due to increased demand. Emerging research fields include its mechanism of action and potential as a therapeutic agent.

Waste containing this compound should be collected in appropriate containers and stored under controlled conditions to prevent degradation. Incineration is a common method for disposal, but professional waste disposal services are recommended for safe handling. Environmental protection measures include minimizing the release of the compound into the environment and adhering to local waste management regulations.